Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 50,845	$ 52,670
Accounts receivable, net of allowances of $287 and $275	10,347	10,098
Inventory	11,016	12,781
Prepaid expenses and other current assets	3,373	2,522
Total current assets	75,581	78,071
Property and equipment, net	2,226	2,341
Intangible assets, net	1,359	1,739
Right-of-use assets	1,502	1,738
Other long-term assets	500	2,276
Deferred tax asset, net		140
Restricted cash	250	265
Total assets	81,418	86,570
Current liabilities:
Accounts payable	2,309	2,147
Accrued expenses and other current liabilities	15,666	13,451
Total current liabilities	17,975	15,598
Long-term debt	55,653	41,124
Other long-term liabilities	1,477	1,390
Total liabilities	75,105	58,112
Commitments and contingencies (Note 12)
Stockholders' equity:
Preferred stock; $0.001 par value: 10,000,000 shares authorized; no shares issued and outstanding
Common stock; $0.001 par value: 200,000,000 shares authorized; 44,538,264 and 39,395,712 shares issued and outstanding at December 31, 2025 and 2024, respectively	44	39
Additional paid-in capital	403,739	387,059
Accumulated other comprehensive income	91	90
Accumulated deficit	(397,561)	(358,730)
Total stockholders' equity	6,313	28,458
Total liabilities and stockholders' equity	$ 81,418	$ 86,570